Walgreens Boots Alliance Inc (NASDAQ:WBA) insider Stefano Pessina purchased 98,858 shares of the stock in a transaction on Monday, January 15th. The stock was acquired at an average price of $76.07 per share, with a total value of $7,520,128.06. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Walgreens Boots Alliance Inc (WBA) opened at $76.00 on Friday. The company has a market capitalization of $75,270.00, a P/E ratio of 20.99, a P/E/G ratio of 1.29 and a beta of 1.22. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. Walgreens Boots Alliance Inc has a 52-week low of $63.82 and a 52-week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, topping the consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. Walgreens Boots Alliance’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.10 EPS. analysts predict that Walgreens Boots Alliance Inc will post 5.7 earnings per share for the current fiscal year.

Walgreens Boots Alliance declared that its board has approved a stock repurchase program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback programs are often a sign that the company’s board believes its stock is undervalued.

Institutional investors have recently added to or reduced their stakes in the stock. Pathstone Family Office LLC raised its position in shares of Walgreens Boots Alliance by 226.6% in the 2nd quarter. Pathstone Family Office LLC now owns 1,179 shares of the pharmacy operator’s stock valued at $1,969,000 after purchasing an additional 818 shares in the last quarter. Hudock Capital Group LLC raised its position in shares of Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares in the last quarter. Westside Investment Management Inc. raised its position in shares of Walgreens Boots Alliance by 10.4% in the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 125 shares in the last quarter. Zions Bancorporation raised its position in shares of Walgreens Boots Alliance by 983.3% in the 3rd quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock valued at $105,000 after purchasing an additional 1,239 shares in the last quarter. Finally, Bristlecone Advisors LLC acquired a new position in shares of Walgreens Boots Alliance in the 3rd quarter valued at approximately $135,000. 61.20% of the stock is currently owned by hedge funds and other institutional investors.

WBA has been the subject of several recent analyst reports. Morgan Stanley cut Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $95.00 to $85.00 in a report on Friday, October 6th. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday, November 10th. Vetr upgraded Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 12th. Robert W. Baird reiterated an “outperform” rating and set a $80.00 target price (down previously from $90.00) on shares of Walgreens Boots Alliance in a report on Thursday, October 19th. They noted that the move was a valuation call. Finally, Citigroup decreased their target price on Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating for the company in a report on Thursday, November 2nd. Nine equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $86.20.

COPYRIGHT VIOLATION NOTICE: “Insider Buying: Walgreens Boots Alliance Inc (WBA) Insider Buys 98,858 Shares of Stock” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The original version of this piece of content can be read at https://www.thecerbatgem.com/2018/01/19/insider-buying-walgreens-boots-alliance-inc-wba-insider-buys-98858-shares-of-stock.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.